NIRS could noninvasively measure the regional cerebral oxygenated hemoglobin (oxyhemoglobin), deoxyhemoglobin, and total hemoglobin concentration
In a prespecified time-to-benefit secondary analysis presented at the European Congress on Obesity in 2025 and subsequently published, semaglutide produced a nominally significant reduction in MACE within the first 3 months (HR 0.63, 95% CI 0.410.95) and the first 6 months (HR 0.60, 95% CI 0.440.81), with curve separation visible within approximately 3 weeks of randomization [25], [26]
Semaglutide Tablets (Rybelsus) Currently, the primary oral semaglutide tablet available in the UK is branded as Rybelsus
I hope this helps clarify some of your questions about Tirzepatide and its impressive dual action
I get IV infusions of various vitamins and minerals as I'm chronically deficient - sadly these aren't available on the NHS so I'm grateful that I can access them elsewhere as oral supplementation is either ineffective or result in inhibitory side effects